Portal de Periódicos da CAPES

Biomarker Value of B Cell-based CCL4L2 in Differential Diagnosis of Autoimmune Inflammatory Demyelinating Disorders (P8-6.008)

2024; Lippincott Williams & Wilkins; Volume: 102; Issue: 17_supplement_1 Linguagem: Inglês

10.1212/wnl.0000000000204651

1526-632X

Erdem Tüzün, Recai Türkoğlu, Gizem Koral, Elif Şanlı, Zerrin Karaaslan, Hande Yüceer, Tuncay Gündüz, Murat Kürtüncü, Cem İ̇smail Küçükali, Vuslat Yılmaz,

Multiple Sclerosis Research Studies

Due to growing significance of B cells in multiple sclerosis (MS) pathogenesis, we investigated a B cell-based biomarker that could differentiate (MS) with predominant involvement of the spinal cord and optic nerves (MS-SCON) and neuromyelitis optica spectrum disorder (NMOSD).